FA3

Year:
2020

Type of intervention:
Debt &Grants – Innovative Start-up – Prototyping and first production

The company
The company is controlled by an important foreign industrial group that aims to revolutionize the market of syringes in hospitals, renewing the technology and safety of devices.

Why
we
intervened

Path Copy 7Created with Sketch.

The company plans to develop an investment program in Italy in order to start research and
production and to build a flexible corporate structure that allows to encourage its investment plan..

How
we are
intervening

Path Copy 7Created with Sketch.

We have transformed the company in Innovative Start-up in order to maximize the public funding
and tax incentives made available thanks to the Innovative Start-up corporate model. We are
supporting the company in the relationship with banking institutions to access credit.

First outcome

Path Copy 7Created with Sketch.

Being recognized as Innovative Start-up in the Chamber of Commerce, the company will be able to access tax and financial incentives more easily. Thanks to our intervention, the research and development plan will receive important funding from the Smart&Start program.